At a press conference Friday, Marie-Paule Kieny, who leads the WHO Ebola vaccine work, suggested there has been real promise offered from initial tests of two of the vaccines being studied. One comes from Merck and NewLink and the other is licensed by GlaxoSmithKline.
–
While the Ebola epidemic seems to be slowing, people are still dying infections continue. To date, there have been 19,340 cases with 7,518 deaths in the countries most impacted by the epidemic, according to the latest WHO report.
